A negative correlation between adiponectin and central obesity is observed in adults, with lower adiponectin levels associated with metabolic syndrome, generalized atherosclerosis, coronary artery disease, and acute coronary syndromes33,34. Here, ADIPOQ is linked to metabolic syndrome.